RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Regen BioPharma Inc
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.00+0.00 (+50.00%)
Close on Oct 19, 2026
- Market cap
- $92.33K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Regen BioPharma's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Quick Capital, LLC | 10 | 9.90% | 13G (passive) | Sep 10, 2025 |